U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Following the market opening Thursday, the Dow traded down 1% to 33,041.42 while the NASDAQ fell 1.79% to 10,518.14. The S&P 500 also fell, dropping, 1.28% to 3,828.79.
Also check this: Market Volatility Drops Further Following Rebound In US Consumer Confidence
Leading and Lagging Sectors
Health care shares fell by just 0.4% on Thursday. Meanwhile, top gainers in the sector included ProQR Therapeutics N.V. PRQR, up 77%, and ORIC Pharmaceuticals, Inc. ORIC, up 49%.
In trading on Thursday, information technology shares dipped by 2%.
Top Headline
The US economy expanded an annualized 3.2% on quarter in the third quarter, up from 2.9% in the second estimate.
Equities Trading UP
- ProQR Therapeutics N.V. PRQR shares shot up 78% to $2.9485 after the company, along with Eli Lilly, announced the expansion of their licensing and collaboration agreement of new genetic medicines. ProQR will receive an upfront payment of $75 million, plus an equity investment.
- Shares of ORIC Pharmaceuticals, Inc. ORIC got a boost, shooting 50% to $4.49 after the company announced it has entered into a clinical development collaboration for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer and agreed to sell about 5.38 million of its common shares at a price of $4.65 per share to Pfizer for proceeds of approximately $25 million.
- MingZhu Logistics Holdings Limited YGMZ shares were also up, gaining 38% to $5.46 after the company announced a $34 million transportation agreement with Xinjiang Tianfu Yitong Supply Chain Management.
Equities Trading DOWN
- Camber Energy, Inc. CEI shares tumbled 20% to $3.13. Camber Energy recently announced a one-for-fifty reverse-stock-split.
- Shares of Rocket Pharmaceuticals, Inc. RCKT were down 20% to $17.75 after the company issued an update on anticipated registration path for RP-A501 in danon disease following end-of-Phase 1 FDA meeting.
- Westrock Coffee Company, LLC WEST was down, falling 18% to $10.99 after gaining 10% on Wednesday.
Check This Out: Muscle Maker And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Commodities
In commodity news, oil traded up 0.9% to $78.99 while gold traded down 0.9% at $1,808.60.
Silver traded down 1.8% to $23.77 on Thursday while copper fell 0.9% to $3.7770.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 0.9%, London’s FTSE 100 fell 0.1% while Spain’s IBEX 35 Index fell 0.4%. The German DAX dipped 1.2%, French CAC 40 fell 0.9% and Italy’s FTSE MIB Index dipped 1%.
Industrial producer prices in Italy increased 29.4% year-over-year in November. Business investment in the UK dropped by 2.5% on quarter during the third quarter. The British economy grew by 1.9% year-over-year in the third quarter, while current account deficit narrowed to GBP 19.4 billion in the quarter.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with the Japan’s Nikkei gaining 0.46% and Hong Kong’s Hang Seng Index gaining 2.71%. China’s Shanghai Composite Index fell 0.46%.
The index of coincident economic indicators in Japan fell to 99.6 in October from 100.8 in the previous month, while index of leading economic indicators rose to 98.6 in October from 98.2 in September.
Economics
- US jobless claims increased by 2,000 to 216,000 in the week ending December 17, compared to market estimates of 220,000.
- The US economy expanded an annualized 3.2% on quarter in the third quarter, up from 2.9% in the second estimate.
Now Read This: Why Cinemark, Liberty SiriusXM And Other Oversold Majors In The Communication Services Sector Look Promising
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 102,048,470 cases with around 1,114,930 deaths. India confirmed a total of at least 44,677,590 cases and 530,680 deaths, while France reported over 39,025,730 COVID-19 cases with 160,870 deaths. In total, there were at least 659,881,370 cases of COVID-19 worldwide with more than 6,678,920 deaths.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.